All participants were requested to undergo a one-time capillary blood glucose measurement using a handheld blood glucometer (FreeStyle Optium H, manufactured by Abbott Laboratories). Whole blood glucose measures were converted into plasma-equivalent blood glucose by multiplying with 1.11 [20 (link)]. Fasting was defined as reporting to have neither eaten nor drunk anything besides water for at least 12 h. Participants were not instructed to fast prior to the blood glucose measurement. Only 1.1% of participants reported to be fasted at the time of the measurement. Individuals with missing information on whether or not they had fasted (0.3% of participants after excluding individuals with a missing blood glucose measurement) were excluded from this analysis. Diabetes was defined as having responded with “yes” to the question “Do you currently have diabetes?” or having a high plasma-equivalent blood glucose reading (≥ 200 mg/dL [11.1 mmol/L] if participants reported not to have fasted or ≥ 126 mg/dL [7.0 mmol/L] if participants reported to be fasted).
Freestyle optium h
Manufactured by Abbott
Sourced in Australia, United States
The FreeStyle Optium H is a blood glucose monitoring device designed for use in professional healthcare settings. It provides accurate and reliable measurements of blood glucose levels. The device is intended for in vitro diagnostic use only.
Automatically generated - may contain errors
Lab products found in correlation
4 protocols using freestyle optium h
1
Measuring Blood Glucose Levels
2
Measuring Blood Glucose for Diabetes Diagnosis
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood glucose was measured with a portable blood glucose measuring instrument (FreeStyle Optium H, Abbott Laboratories).22 (link) Diabetes was defined as having a high plasma-equivalent blood glucose level of 200 mg/dL or higher (to convert to millimoles per liter, multiply by 0.0555)23 (link) or reporting yes when asked, “Are you currently taking a prescribed medicine to lower blood glucose?” We adopted a cutoff of 200 mg/dL instead of the general cutoff of 126 mg/dL because random blood glucose measurements were taken, meaning that fasting before the test was not required.24 (link)
3
Plasma Biomarker Measurement Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
ELISA kits (MyBioSources, Inc., San Diego, CA, USA) were used to measure plasma irisin (MBS2601445), FGF-21 (MBS030711), and insulin (MBS724709) according to the manufacturer’s instructions. Blood glucose concentration was determined immediately after sampling using a portable glucometer (FreeStyle OptiumH, Abbott Laboratories, Doncaster, Victoria, Australia).
4
Diabetes Management Protocol with Fitness Tracking
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
At the 1st visit of run-in period, the participants received and were instructed how to use glucose meter (Freestyle Optium H, Abbot, USA), and accelerometer (Triaxial accelerometer, Fitbit zip, Fitbit, USA). This accelerometer device has been validated for its accuracy in several trials [13 (link)–17 (link)]. Diabetes education which included insulin injection, detection and correction of hypoglycemia, self-monitoring blood glucose (SMBG), and diet and food choices were provided to all participants. Those food choices included serving and portion size as well as the compositions of nutrients.
During the 1st week of run-in period, the participants recorded the diet in food diary and performed SMBG 6 times for one day (before and 2 hours after breakfast, lunch and dinner). The participants also carried the accelerometer during the day to monitor the steps. In the 2nd week, the participants revisited our clinic to review the food diary and glucose meter use. In this week, participants must walk for 15–20 minutes at least one meal per day. The walk should be started 15–30 minutes after meal. The accelerometer was carried during the day to confirm the walking steps after meal.
During the 1st week of run-in period, the participants recorded the diet in food diary and performed SMBG 6 times for one day (before and 2 hours after breakfast, lunch and dinner). The participants also carried the accelerometer during the day to monitor the steps. In the 2nd week, the participants revisited our clinic to review the food diary and glucose meter use. In this week, participants must walk for 15–20 minutes at least one meal per day. The walk should be started 15–30 minutes after meal. The accelerometer was carried during the day to confirm the walking steps after meal.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!